MedPath

Charité - Universitätsmedizin Berlin

Charité - Universitätsmedizin Berlin logo
🇩🇪Germany
Ownership
Private
Established
1710-01-01
Employees
10K
Market Cap
-
Website
http://www.charite.de

Reconstruction of Monocytic Immunocompetence by Granulocyte-macrophage-colony Stimulating Factor (GM-CSF) in Patients With Severe Sepsis and Septic Shock

Phase 2
Completed
Conditions
Sepsis
Interventions
Biological: GM-CSF (verum)
First Posted Date
2005-11-15
Last Posted Date
2011-05-26
Lead Sponsor
Charite University, Berlin, Germany
Target Recruit Count
38
Registration Number
NCT00252915

Prednisolone in Active Ankylosing Spondylitis (AS)

Phase 2
Conditions
Ankylosing Spondylitis
First Posted Date
2005-10-26
Last Posted Date
2006-09-11
Lead Sponsor
Charite University, Berlin, Germany
Target Recruit Count
75
Registration Number
NCT00244166
Locations
🇩🇪

Charité Campus Benjamin-Franklin Rheumatolgy, Berlin, Germany

🇩🇪

Rheumazentrum Ruhrgebiet, Herne, Germany

🇩🇪

Immanuel Hospital Rheumatology, Berlin, Germany

Intraarticular Opioids Vs Glucocorticosteroids in Gonarthritis

Phase 1
Conditions
Rheumatic Disease
First Posted Date
2005-10-26
Last Posted Date
2006-09-11
Lead Sponsor
Charite University, Berlin, Germany
Target Recruit Count
120
Registration Number
NCT00244153
Locations
🇩🇪

Immanuel Krankenhaus, Berlin, Germany

New Immunomodulatory Therapy Strategies in Chronic Reactive Arthritis

Phase 2
Conditions
Reactive Arthritis
First Posted Date
2005-10-26
Last Posted Date
2006-09-08
Lead Sponsor
Charite University, Berlin, Germany
Target Recruit Count
40
Registration Number
NCT00244179
Locations
🇩🇪

Charite Campus Benjamin Franklin, Rheumatology, Berlin, Germany

Methotrexate in Ankylosing Spondylitis (MTX in AS)

Phase 2
Conditions
Ankylosing Spondylitis
First Posted Date
2005-10-25
Last Posted Date
2005-12-09
Lead Sponsor
Charite University, Berlin, Germany
Target Recruit Count
20
Registration Number
NCT00243750
Locations
🇩🇪

Charité Campus Benjamin-Franklin, Rheumatology, Berlin, Germany

Efficacy and Safety of Amodiaquine and Amodiaquine-Artesunate

Phase 4
Conditions
Malaria
First Posted Date
2005-10-13
Last Posted Date
2006-02-02
Lead Sponsor
Charite University, Berlin, Germany
Target Recruit Count
400
Registration Number
NCT00238017
Locations
🇬🇭

University for Development Studies, Tamale, Northern Region, Ghana

D2E7-Early AS

Phase 2
Conditions
Ankylosing Spondylitis
First Posted Date
2005-10-10
Last Posted Date
2005-12-09
Lead Sponsor
Charite University, Berlin, Germany
Target Recruit Count
46
Registration Number
NCT00235105
Locations
🇩🇪

Rheumazentrum Ruhrgebiet, Herne, Germany

🇩🇪

Charité Campus Benjamin Franklin, Rheumatology, Berlin, Germany

Investigation of a Combination Treatment of Escitalopram and rTMS

Not Applicable
Completed
Conditions
Major Depressive Disorder
First Posted Date
2005-10-05
Last Posted Date
2011-06-23
Lead Sponsor
Charite University, Berlin, Germany
Target Recruit Count
42
Registration Number
NCT00232700
Locations
🇩🇪

Department of Psychiatry, Charité - Universitaetsmedizin Berlin, Campus Benjamin Franklin, Berlin, Germany

Pilot-Study of Thalidomide in Amyotrophic Lateral Sclerosis (ALS)

Phase 2
Terminated
Conditions
Amyotrophic Lateral Sclerosis (ALS)
First Posted Date
2005-10-04
Last Posted Date
2007-01-19
Lead Sponsor
Charite University, Berlin, Germany
Target Recruit Count
40
Registration Number
NCT00231140
Locations
🇩🇪

Charite University Hospital, Berlin, Germany, Berlin, Germany

Trial of Levofloxacin as Prophylaxis After Allogeneic Stem Cell Transplantation (SCT)

Phase 2
Conditions
Malignancy
Allogeneic Stem Cell Transplantation
First Posted Date
2005-09-22
Last Posted Date
2007-11-30
Lead Sponsor
Charite University, Berlin, Germany
Registration Number
NCT00215007
Locations
🇩🇪

Charite, CBF, Berlin, Germany

© Copyright 2025. All Rights Reserved by MedPath